Your body uses cysteine to make proteins and other important compounds, but NAC works differently because it's more stable and easier for your body to absorb
SURMOUNT-5 was a 72-week, multi-centre, randomised, open-label, Phase 3b trial evaluating the efficacy and safety of tirzepatide compared with semaglutide in adults with obesity, or overweight with at least one of the following comorbidities: hypertension, dyslipidaemia, obstructive sleep apnoea (OSA) or cardiovascular disease, who did not have diabetes
Finan B, Mller TD, Clemmensen C, Perez-Tilve D, DiMarchi RD, Tschp MH
It is important to remember, however, that this trial was an open-label study that is to say, the participants knew that they were receiving the exenatide treatment so there is the possibility of a placebo effect explaining the improvements